Test Price
2,800 AEDโ Home Collection Available
ALG9 Gene Genetic Test for Congenital Disorder of Glycosylation Type 1L (CDG-IL) in UAE | 2800 AED
Executive Summary & Core Metrics
This ALG9 Gene Test offers 99.9% diagnostic sensitivity for Congenital Disorder of Glycosylation Type 1L (CDG-IL), processed under ISO 9001:2015 certified laboratory with strict UAE PDPL data privacy. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM. Post-test genetic counselling telephonic sessions and direct insurance billing via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ALG9 gene encodes an alpha-1,2-mannosyltransferase essential for protein glycosylation; pathogenic variants cause Congenital Disorder of Glycosylation Type 1L, leading to multi-system involvement (neurological, hepatic, coagulopathic). This next-generation sequencing (NGS) assay analyzes the entire coding region and splice sites to identify single nucleotide variants, small indels, and copy number variations, providing a definitive molecular diagnosis with near-100% analytical accuracy.
| Feature | Our ALG9 NGS Test (DHA Lab) | Closest Alternative (Single-gene Sanger) |
|---|---|---|
| Precision | 99.9% analytical sensitivity / specificity (NGS + orthogonal confirmation) | ~95% analytical sensitivity; limited to point mutations |
| Methodology | Illumina NGS with 100x minimum coverage, CNV detection | Sanger sequencing of exons only |
| Turnaround Time | 15–20 working days (expedited available) | 3–4 weeks |
| Sample & Pre-test Support | Blood, FTA card, or extracted DNA; included genetic counselling + pedigree | Blood only; no prior counselling |
| Regulatory Compliance | DHA license 1143, ISO 9001:2015, UAE PDPL, Federal Law No. 2 of 2019 | Variable |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I emphasize that the ALG9 NGS result is a powerful diagnostic tool but must be clinically correlated with the patient's phenotype and biochemistry. A positive variant confirms the molecular etiology; a negative result does not exclude other glycosylation defects. Hence, comprehensive genetic counselling and follow-up with a metabolic physician are essential."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
๐จ Do not discontinue prescribed medication without consulting your doctor.
This genetic test may influence treatment decisions; however, altering therapy should be done only under medical supervision. Follow your physician's guidance strictly.
Exclusion Criteria & ER Red Flags
- Active infection or febrile illness (resample after recovery).
- Severe anemia or coagulopathy contraindicating venipuncture (use FTA card).
- Recent blood transfusion (may cause genotypic interference).
- Minors: valid parental consent mandated per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- If the patient experiences acute neurological deterioration, seizures, or bleeding, seek emergency care immediately before anticipating test results.
Patient FAQ & Clinical Guidance
1. How long does it take to receive the ALG9 genetic test result?
Your report, validated by a clinical geneticist, will be ready in 15–20 working days from sample receipt. Our expedited service (<10 days) is available upon request; we also provide telephonic pre- and post-test genetic counselling to interpret findings in the patientโs clinical context. Please ensure completion of the mandatory pedigree session before sample collection.
2. What sample types are accepted, and what preparation is required?
We accept whole blood (EDTA tube), extracted DNA, or a single drop of blood on an FTA card. For blood draw, no fasting is required; however, genetic counselling with a pedigree chart of affected relatives is mandatory prior to testing to maximize diagnostic yield. Our home collection team carries ISO-certified cold-chain containers to preserve sample integrity during transport.
3. Is this test covered by insurance, and how do I verify?
Direct insurance billing is available for most UAE plans; send your insurance card via WhatsApp to +971 54 548 8731 for immediate verification. Our billing team will confirm coverage and obtain pre-authorization within 2 hours, allowing you to proceed with zero out-of-pocket expense. The test complies with DHA standards and international diagnostic criteria (CDG-IL).
UAE Regulatory & Data Privacy Adherence
Data Protection: This genetic test is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data are encrypted and processed with strict confidentiality.
Clinical Safety: Consent and safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring proper patient consent and clinical oversight.
Clinical & Logistical Metadata
| Test Name | ALG9 Gene Genetic Test for Congenital Disorder of Glycosylation Type 1L (CDG-IL) |
| Price (AED) | 2,800 |
| Turnaround Time | 15–20 working days |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card |
| Methodology Used | Next-generation sequencing (NGS) with CNV detection |
| ICD-10-CM Code | E77.8 |
| LOINC Code | 81265-0 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians